Click to hear Dr Baglin's perspective on the role of the laboratory in treatment with new oral
anticoagulants Summary One of the key benefits of the direct oral anticoagulants (DOACs) is …

The introduction of direct oral anticoagulants (DOACs), such as dabigatran, rivaroxaban,
apixaban, edoxaban, and betrixaban, provides safe and effective alternative to previous …

In 2018, the International Council for Standardization in Haematology (ICSH) published a
consensus document providing guidance for laboratories on measuring direct oral …

Direct oral anticoagulants (DOACs) have significantly improved the care of patients requiring
anticoagulation. With similar or better efficacy and safety outcomes and easier use in the …

Abstract Background Oral factor Xa inhibitors (FXaI) can be administered in fixed doses
without the need for routine laboratory monitoring. Anti-Xa assays can estimate …

The availability of direct oral anticoagulants (DOAC s) has led to a paradigm shift in the field
of anticoagulation, with DOAC s increasingly being prescribed for patients in preference to …

Direct oral anticoagulants (dabigatran, rivaroxaban, apixaban and edoxaban; DOACs) have
been introduced to improve safety and superior therapeutic value compared to their …

There are no clear and consistent guidelines on how to utilize DOAC assays, and reports on
the use of DOAC levels in clinical practice is limited. The objective of this study was to …

BACKGROUND Anticoagulation is essential for the treatment and prevention of
thromboembolic events. Current guidelines recommend direct oral anticoagulants (DOACs) …

Objectives: Identify the indications of rivaroxaban therapy. Describe the mechanism of action
of rivaroxaban. Outline the contraindications in a patient on rivaroxaban therapy. Review the …